Myovant Sciences Ltd. Services Agreements
9 Contracts & Agreements
- Amendment No. 4 to Market Access Services Agreement by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH, dated August 9, 2022 (Filed With SEC on October 26, 2022)
- Amendment No. 3 to Market Access Services Agreement by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH, dated March 15, 2021 (Filed With SEC on October 26, 2022)
- Amended and Restated Manufacturing & Services Agreement by and between Excella GmbH & Co. KG and Myovant Sciences GmbH, dated April 2, 2021 (Filed With SEC on October 26, 2022)
- Amendment No.2 to Market Access Services Agreement, dated as of January 25, 2021, by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH (Filed With SEC on May 11, 2021)
- Amendment No.1 to Market Access Services Agreement, dated as of (Filed With SEC on February 11, 2021)
- Market Access Services Agreement, dated as of August 1, 2020, by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH (Filed With SEC on November 12, 2020)
- SERVICES AGREEMENT (Filed With SEC on February 13, 2017)
- AMENDED AND RESTATED SERVICES AGREEMENT (Filed With SEC on February 13, 2017)
- SERVICESAGREEMENT (Filed With SEC on September 30, 2016)
